Aligos Therapeutics said on Thursday its experimental treatment for a serious type of fatty liver disease helped significantly reduce liver fat, meeting the main goal of a mid-stage study.
A study reveals advances in the understanding and treatment of liver fibrosis, a serious complication in the context of metabolic fatty liver disease, also known as MASLD (metabolic ...